Tumor necrosis factor alpha (TNF-α) blockade improves natural killer cell (NK) activation, hypertension, and mitochondrial oxidative stress in a preclinical rat model of preeclampsia

ABSTRACT The RUPP rat model of Preeclampsia exhibits hypertension (MAP), cytolytic natural killer (cNK) cells, tumor necrosis factor alpha (TNF-α) and mitochondrial Reactive Oxygen Species (mt ROS). Objective: Does TNF-α blockade with ETAN (Etanercept) decrease cNK cell and mt ROS in RUPP rats. Methods: On gestational day 14, RUPP surgery was performed, ETAN (0.4 mg/kg) was administered on day 18, MAP, blood and tissues collected on 19. Results:MAP, cytolytic NK cells and mt ROS were elevated in RUPP vs. NP and normalized with ETAN. Conclusion: TNF-α blockade lowered blood pressure and improve inflammation and organ function in response to placental ischemia.

[1]  L. Amaral,et al.  17-Hydroxyprogesterone caproate improves T cells and NK cells in response to placental ischemia; new mechanisms of action for an old drug. , 2019, Pregnancy hypertension.

[2]  G. Wallukat,et al.  Blockade of endogenous Angiotensin II type I receptor agonistic autoantibody activity improves mitochondria reactive oxygen species and hypertension in a rat model of Preeclampsia. , 2019, American journal of physiology. Regulatory, integrative and comparative physiology.

[3]  L. Amaral,et al.  Natural killer cells contribute to mitochondrial dysfunction in response to placental ischemia in reduced uterine perfusion pressure rats. , 2019, American journal of physiology. Regulatory, integrative and comparative physiology.

[4]  G. Wallukat,et al.  Renal natural killer cell activation and mitochondrial oxidative stress; new mechanisms in AT1-AA mediated hypertensive pregnancy. , 2018, Pregnancy hypertension.

[5]  L. Amaral,et al.  Role of Mitochondrial Dysfunction and Reactive Oxygen Species in Mediating Hypertension in the Reduced Uterine Perfusion Pressure Rat Model of Preeclampsia , 2018, Hypertension.

[6]  L. Amaral,et al.  AT1-AA (Angiotensin II Type 1 Receptor Agonistic Autoantibody) Blockade Prevents Preeclamptic Symptoms in Placental Ischemic Rats , 2018, Hypertension.

[7]  L. Amaral,et al.  Natural killer cells mediate pathophysiology in response to reduced uterine perfusion pressure. , 2017, Clinical science.

[8]  D. Martinvalet,et al.  Granzyme B enters the mitochondria in a Sam50-, Tim22- and mtHsp70-dependent manner to induce apoptosis , 2017, Cell Death and Differentiation.

[9]  G. Wallukat,et al.  Agonistic Autoantibodies to the Angiotensin II Type 1 Receptor Enhance Angiotensin II–Induced Renal Vascular Sensitivity and Reduce Renal Function During Pregnancy , 2016, Hypertension.

[10]  L. Amaral,et al.  Identifying immune mechanisms mediating the hypertension during preeclampsia. , 2016, American journal of physiology. Regulatory, integrative and comparative physiology.

[11]  L. Amaral,et al.  Placental Ischemia and Resultant Phenotype in Animal Models of Preeclampsia , 2016, Current Hypertension Reports.

[12]  M. Chimenti,et al.  Restoration of peripheral blood natural killer and B cell levels in patients affected by rheumatoid and psoriatic arthritis during etanercept treatment , 2014, Clinical and experimental immunology.

[13]  A. Ornoy,et al.  Pregnancy outcome following gestational exposure to TNF-alpha-inhibitors: a prospective, comparative, observational study. , 2014, Reproductive toxicology.

[14]  J. Gisbert,et al.  Safety of Anti-TNF Agents During Pregnancy and Breastfeeding in Women With Inflammatory Bowel Disease , 2013, The American Journal of Gastroenterology.

[15]  O. Nielsen,et al.  Safety of TNF-α inhibitors during IBD pregnancy: a systematic review , 2013, BMC Medicine.

[16]  J. Garvin,et al.  Tumor necrosis factor-α: regulation of renal function and blood pressure. , 2013, American journal of physiology. Renal physiology.

[17]  J. Granger,et al.  Control of soluble fms-like tyrosine-1 (sFlt-1) production response to placental ischemia/hypoxia: role of tumor necrosis factor-α. , 2013, American journal of physiology. Regulatory, integrative and comparative physiology.

[18]  A. Górski,et al.  Etanercept immunotherapy in women with a history of recurrent reproductive failure. , 2012, Ginekologia polska.

[19]  J. Granger,et al.  Changes in cardiac structure in hypertension produced by placental ischemia in pregnant rats: effect of tumor necrosis factor blockade , 2011, Journal of hypertension.

[20]  G. Wallukat,et al.  The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy. , 2010, American journal of hypertension.

[21]  E. Bonfá,et al.  Immunogenicity of Anti-TNF-α Agents in Autoimmune Diseases , 2010, Clinical reviews in allergy & immunology.

[22]  G. Wallukat,et al.  Autoantibodies to the Angiotensin Type I Receptor in Response to Placental Ischemia and Tumor Necrosis Factor &agr; in Pregnant Rats , 2008, Hypertension.

[23]  J. Granger,et al.  Hypertension in Response to Chronic Reductions in Uterine Perfusion in Pregnant Rats: Effect of Tumor Necrosis Factor-&agr; Blockade , 2008, Hypertension.

[24]  G. Saade,et al.  Gender-specific effect of overexpression of sFlt-1 in pregnant mice on fetal programming of blood pressure in the offspring later in life. , 2007, American journal of obstetrics and gynecology.

[25]  J. Granger,et al.  Hypertension Produced by Reductions in Uterine Perfusion in the Pregnant Rat: Role of Tumor Necrosis Factor-&agr; , 2005, Hypertension.

[26]  J. Granger,et al.  Role of Endothelin in Mediating Tumor Necrosis Factor-Induced Hypertension in Pregnant Rats , 2005, Hypertension.

[27]  J. Granger,et al.  Tumor necrosis factor-alpha-induced hypertension in pregnant rats results in decreased renal neuronal nitric oxide synthase expression. , 2002, American journal of hypertension.

[28]  K. Conrad,et al.  Circulating Levels of Immunoreactive Cytokines in Women with Preeclampsia , 1998, American journal of reproductive immunology.

[29]  N. Thornberry,et al.  Granzyme B directly and efficiently cleaves several downstream caspase substrates: implications for CTL-induced apoptosis. , 1998, Immunity.

[30]  K. Conrad,et al.  Placental Cytokines and the Pathogenesis of Preeclampsia , 1997, American journal of reproductive immunology.

[31]  Z. Ba,et al.  Administration of tumor necrosis factor-alpha in vivo depresses endothelium-dependent relaxation. , 1994, The American journal of physiology.

[32]  A. M. Lefer,et al.  Cytokines and growth factors in endothelial dysfunction , 1993, Critical care medicine.

[33]  R. Cotran,et al.  Cytokines and endothelial cell biology. , 1990, Physiological reviews.